Improved survival in patients with breast rhabdoid tumors with multi-agent adjuvant chemotherapy combined with irradiation

• Published in: Cancer chemotherapy and pharmacology Vol. 64; no. 3; pp. 623 - 627
• Main Authors: Furuya, Yoshitaka, Yanagie, Hironobu, Wakahara, Takashi, Mishina, Yoshiya, Akimoto, Harutoshi, Quang, Le Minh, Hiroshima, Kenzo, Yasuhara, Hiroshi
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Berlin/Heidelberg : Springer-Verlag 01.07.2009; Springer-Verlag; Springer; Springer Nature B.V
• Subjects: Aged; Antineoplastic agents; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biological and medical sciences; Breast Neoplasms - physiopathology; Breast Neoplasms - therapy; Cancer Research; Chemotherapy, Adjuvant - methods; Combined Modality Therapy; Female; Follow-Up Studies; Gynecology. Andrology. Obstetrics; Humans; Mammary gland diseases; Mastectomy; Medical sciences; Medicine; Medicine & Public Health; Neoplasm Metastasis; Oncology; Pharmacology. Drug treatments; Pharmacology/Toxicology; Rhabdoid Tumor - physiopathology; Rhabdoid Tumor - therapy; Short Communication; Survival Rate; Tumors; Rhabdoid tumor; Breast; Irradiation; Chemotherapy; Human; Drug combination; Breast tumor; Adjuvant treatment; Patient; Survival; Mammary gland diseases; Treatment; Combined treatment; Mammary gland

Purpose Malignant rhabdoid tumors (MRT) have poor prognoses. Breast MRT is extremely rare; only three cases have been documented, with a mean prognosis of 7 months. Multi-agent chemotherapy with mastectomy and irradiation, as used in this case, may extend survival in breast MRT. Patient and methods...